-+ 0.00%
-+ 0.00%
-+ 0.00%
Ono Pharmaceutical has entered into an exclusive license agreement with a US biopharmaceutical company for a new drug candidate in Japan and ASEAN countries.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending